-transparent.png){kind=logo}
Are MHC class II-restricted cytotoxic T lymphocytes important? 1987
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, incorporating the Laboratory of Experimental and Clinical Immunology of the University of Amsterdam, PO Box 9406, 1006 AK Amsterdam, The Netherlands.
Although most cytotoxic T lymphocytes (CTL) are MHC class I restricted and most helper T cells class II restricted, some CTL are MHC class II restricted. The function of these cells is unclear. Here, Eric Braakman and co-workers suggest that they are an important regulatory influence, appearing late in the immune response and destroying cells presenting antigen in the context of class II molecules. The elimination of these cells inhibits the generation of the helper T response and consequently terminates the immune response to that antigen.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
E Braakman, and
F T Rotteveel, and
G van Bleek, and
G A van Seventer, and
C J Lucas
September 1990,
Immunology,
E Braakman, and
F T Rotteveel, and
G van Bleek, and
G A van Seventer, and
C J Lucas
March 2013,
Nature immunology,
E Braakman, and
F T Rotteveel, and
G van Bleek, and
G A van Seventer, and
C J Lucas
August 1987,
Immunological reviews,
E Braakman, and
F T Rotteveel, and
G van Bleek, and
G A van Seventer, and
C J Lucas
May 1992,
Journal of immunology (Baltimore, Md. : 1950),
E Braakman, and
F T Rotteveel, and
G van Bleek, and
G A van Seventer, and
C J Lucas
April 1988,
AIDS (London, England),
E Braakman, and
F T Rotteveel, and
G van Bleek, and
G A van Seventer, and
C J Lucas
November 1994,
Biological chemistry Hoppe-Seyler,
E Braakman, and
F T Rotteveel, and
G van Bleek, and
G A van Seventer, and
C J Lucas
April 1994,
Cellular immunology,
E Braakman, and
F T Rotteveel, and
G van Bleek, and
G A van Seventer, and
C J Lucas
March 2001,
International immunology,
E Braakman, and
F T Rotteveel, and
G van Bleek, and
G A van Seventer, and
C J Lucas
December 1986,
Journal of immunology (Baltimore, Md. : 1950),
E Braakman, and
F T Rotteveel, and
G van Bleek, and
G A van Seventer, and
C J Lucas
January 1993,
Vaccine,
